Factors related to clinical relapse in patients with chronic hepatitis B after withdrawal of nucleos(t)ide analogues
10.3760/cma.j.issn.1674-2397.2015.06.014
- VernacularTitle:慢性乙型肝炎核苷(酸)类药物治疗停药后复发的相关影响因素
- Author:
Yuanwang QIU
;
Lihua HUANG
;
Jianhe GAN
- Publication Type:Journal Article
- Keywords:
Hepatitis B,chronic;
Antiviral agents;
Withdrawal;
Recurrence;
Risk factors
- From:
Chinese Journal of Clinical Infectious Diseases
2015;8(6):567-570
- CountryChina
- Language:Chinese
-
Abstract:
Oral anti-viral agents nucleos (t)ide analogues (NAs) are widely used in treatment of chronic hepatitis B (CHB) since they are well-tolerated in most patients.But clinical relapse occurs in a considerable part of patients after the cessation of NAs therapy.This paper reviews factors related to clinical relapse, including time for drug withdrawal, cccDNA level, age, baseline alanine aminotransferase (ALT) and HBV DNA levels, type of NAs, serum level of HBsAg and the immune status of patients.
